THIRD ROCK VENTURES IV, L.P. reported 2 transactions at MAZE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/4/2025ACC: 0000950170-25-013760
10% Owner
Since Jan 2025
-58.01M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
6.71M acquired · 64.73M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.76M
Price / share
—
Trade value
—
% of position
1852.0%
2/3/2025
311.17K→6.07M
Common Stock
Indirect
Shares
+950.80K
Price / share
—
Trade value
—
% of position
New position
2/3/2025
0.00→950.80K
Total
Net shares
+6.71M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | C · Conversion | +5.76M | — | — | 1852.0% | 311.17K | 6.07M |
| Common Stock Indirect | 2/3/2025 | C · Conversion | +950.80K | — | — | New position | 0.00 | 950.80K |
| Total | +6.71M | $0.00 | ||||||
Derivative Transactions3
Series A Preferred Stock
Direct
Converts to
Common Stock
4.75M shares
Shares
−45.83M
Strike price
Held after
0.00
Exercisable
—
2/3/2025
Series D-1 Preferred Stock
Direct
Converts to
Common Stock
1.01M shares
Shares
−9.73M
Strike price
Held after
0.00
Exercisable
—
2/3/2025
Series A Preferred Stock
Indirect
Converts to
Common Stock
950.80K shares
Shares
−9.17M
Strike price
Held after
0.00
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock4.75M shares | 2/3/2025 | C · Conversion | −45.83M | — | 0.00 | |
| Series D-1 Preferred Stock Direct | Common Stock1.01M shares | 2/3/2025 | C · Conversion | −9.73M | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock950.80K shares | 2/3/2025 | C · Conversion | −9.17M | — | 0.00 |